Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,702 | -872 | -3,918 | -2,496 | -1,802 |
| Depreciation Amortization | 390 | 215 | 153 | 116 | 76 |
| Accounts receivable | -177 | -249 | 105 | 79 | 251 |
| Other Working Capital | 138 | -94 | -19 | -372 | 241 |
| Other Operating Activity | 186 | 254 | 1,456 | 921 | 379 |
| Operating Cash Flow | $-1,165 | $-746 | $-2,223 | $-1,752 | $-855 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -52 | -48 | -38 | -37 |
| Purchase Of Investment | N/A | N/A | -16 | -8 | -8 |
| Investing Cash Flow | $-61 | $-52 | $-64 | $-46 | $-45 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 146 | 20 | 4,117 | 4,095 | 3,706 |
| Financing Cash Flow | $146 | $20 | $4,117 | $4,095 | $3,706 |
| Beginning Cash Position | 1,923 | 1,923 | 93 | 93 | 93 |
| End Cash Position | 843 | 1,145 | 1,923 | 2,390 | 2,899 |
| Net Cash Flow | $-1,080 | $-778 | $1,830 | $2,297 | $2,806 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,165 | -746 | -2,223 | -1,752 | -855 |
| Capital Expenditure | -61 | -52 | -48 | -38 | -37 |
| Free Cash Flow | -1,226 | -798 | -2,271 | -1,790 | -892 |